Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
27.12
+3.66 (15.60%)
At close: May 22, 2026, 4:00 PM EDT
23.30
-3.82 (-14.09%)
After-hours: May 22, 2026, 7:59 PM EDT
Akanda Revenue
Akanda had revenue of $836.66K in the twelve months ending June 30, 2025, up 183.67% year-over-year. In the year 2024, Akanda had annual revenue of $836.66K with 97.47% growth.
Revenue (ttm)
$836.66K
Revenue Growth
+183.67%
P/S Ratio
17.32
Revenue / Employee
$18,188
Employees
46
Market Cap
14.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 836.66K | 412.98K | 97.47% |
| Dec 31, 2023 | 423.68K | -2.20M | -83.83% |
| Dec 31, 2022 | 2.62M | 2.58M | 6,223.00% |
| Dec 31, 2021 | 41.43K | 39.37K | 1,909.26% |
| Dec 31, 2020 | 2.06K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rockwell Medical | 67.68M |
| Aytu BioPharma | 56.60M |
| Biofrontera | 43.20M |
| cbdMD | 19.98M |
| InMed Pharmaceuticals | 4.94M |
| China Pharma Holdings | 3.99M |
| TherapeuticsMD | 3.35M |
| China SXT Pharmaceuticals | 1.54M |
AKAN News
- 1 day ago - Akanda Corp. Announces Receipt of NASDAQ Noncompliance Letter - Newsfile Corp
- 1 day ago - Akanda Corp. Announces Cancellation of Special Meeting - Newsfile Corp
- 3 days ago - Akanda Corp trading resumes - TheFly
- 3 days ago - Akanda Corp trading halted, volatility trading pause - TheFly
- 16 days ago - Akanda Corp trading halted, volatility trading pause - TheFly
- 16 days ago - Akanda Corp trading resumes - TheFly
- 19 days ago - Akanda Corp trading resumes - TheFly
- 19 days ago - Akanda Corp trading halted, volatility trading pause - TheFly